They also suggest additional workup for T1c N0 (i.e., stage I with a primary tumor >1 cm) in case of HER2+ BC or triple negative (ER-/PR-/HER2-) breast cancer (TNBC) [8]. This evidence concerns the gene ESR1 and breast carcinoma.